Background illustration for clinical trials search

Paid Clinical Trials Raleigh

Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

DILIN - Prospective Study

for
Liver Diseases
Location: Chapel Hill NC, Bethesda MD, Philadelphia PA,
Sponsor: Duke University

Sex: All

Age: 2+

Code: NCT00345930

Recruiting
Active & Responsive

Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART

for
Diabetes type1, Diabetes Mellitus, Type 1, Diabetes, Autoimmune,
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 30+

Code: NCT06405373

Recruiting
Active & Responsive

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

for
Oropharyngeal Squamous Cell Carcinoma, Carcinoma, Squamous Cell,
Location: Chapel Hill NC, North Charleston SC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04564989

Recruiting
Active & Responsive

A 52-week Study of Remibrutinib in IgE-mediated Food Allergy

for
IgE-Mediated Food Allergy, Peanut Allergy, Cow Milk Allergy,
Location: Chapel Hill NC, North Charleston SC, Chevy Chase MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 65

Code: NCT07768371

Phase 3, Recruiting
Active & Responsive

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for
Colorectal Cancer
Location: Chapel Hill NC, Charlottesville VA, Fairfax VA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07659795

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

for
Trachoma, Eye Diseases, Trichiasis
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07322302

Recruiting
Active & Responsive

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

for
Bronchopulmonary Dysplasia (BPD), Premature Births,
Location: Chapel Hill NC, Greenville NC, Amherst MA,
Sponsor: Duke University

Sex: All

Age: 0

Code: NCT07101640

Phase 1, Phase 2, Recruiting
Active & Responsive

NEPTUNE Match Study

for
Nephrotic Syndrome in Children,
Location: Chapel Hill NC, Charlotte SC, Baltimore MD,
Sponsor: University of Michigan

Sex: All

Age: 1 - 70+

Code: NCT04571658

Recruiting
Active & Responsive

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: Chapel Hill NC, Winston-Salem NC, Charlotte NC,
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07237516

Recruiting
Active & Responsive

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Chapel Hill NC, Washington D.C. DC, Pittsburgh PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 70+

Code: NCT06997588

Phase 2, Recruiting
Active & Responsive

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for
AML With Gene Mutations
Location: Chapel Hill NC, College Park MD, Atlanta GA,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06366789

Phase 1, Recruiting
Active & Responsive

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

for
CLL / SLL, CLL (Chronic Lymphocytic Leukemia),
Location: Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06708897

Phase 1, Recruiting
Active & Responsive

Rifaximin for the Secondary Prevention of Recurrent Pouchitis

for
Pouchitis
Location: Chapel Hill NC, New York NY
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18 - 70+

Code: NCT06312683

Phase 4, Recruiting
Active & Responsive

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

for
Myasthenia Gravis, Myasthenia Gravis, MuSK
Location: Chapel Hill NC, Augusta GA, Columbus OH, Tampa FL,
Sponsor: NMD Pharma A/S

Sex: All

Age: 18+

Code: NCT06414954

Phase 2, Recruiting
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Chapel Hill NC, Baltimore MD, Philadelphia PA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase 2, Recruiting
Active & Responsive

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: Chapel Hill NC, Bethesda MD, Philadelphia PA,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 3+

Code: NCT02523118

Recruiting
Active & Responsive

Graded Exposure and Mindfulness Meditation for Patients Post-ACL Reconstruction

for
Anterior Cruciate Ligament Injuries
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 14 - 35

Code: NCT05949177

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Location: Chapel Hill NC, Atlanta GA, Jacksonville FL,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07284758

Phase 2, Recruiting
Active & Responsive

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

for
Juvenile Psoriatic Arthritis
Location: Chapel Hill NC, Washington D.C. DC, Cleveland OH,
Sponsor: AbbVie

Sex: All

Age: 5 - 17

Code: NCT06100744

Phase 3, Recruiting
Active & Responsive

Impacts of Sugar Warnings on Weight Bias

for
Nutrition, Diet Interventions
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07346001

Recruiting